NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR), today announced positive topline data from VESPER-1 and positive data from a planned interim analysis for tolerability of ...
Arthrosi Therapeutics has raised $153 million to bankroll its bid to clout gout. The series E financing gives the biotech the financial firepower to deliver data from two phase 3 trials next year. San ...
AstraZeneca has hailed another phase 3 win for its blood pressure drug candidate baxdrostat, boosting its attempts to turn the molecule’s long half-life into a competitive advantage. Baxdrostat, an ...
Prime Minister Narendra Modi will inaugurate the final phase of Mumbai Metro Aqua Line-3 on October 9, 2025. This Rs 12,000 crore phase connects business hubs, entertainment zones, and the airport, ...
Adding Repatha to Standard Therapy of Statins or Other LDL-C Lowering Treatments Significantly Reduces Cardiovascular Events Compared with Standard Therapy Alone Repatha is Now the First and Only ...
Prime Minister Narendra Modi on Wednesday (October 8, 2025) inaugurated the final phase of Mumbai’s first fully underground Metro 3, making 33.5-km Aqua Line operational, which will connect Aarey in ...
The firm’s analysis was influenced by the progress of Moonlake’s Phase III VELA clinical trials for sonelokimab in treating hidradenitis suppurativa. The VELA-2 trial has completed its last patient ...
NEW DELHI: A top executive of homegrown telecom gear maker HFCL said it has won deals in 40-45% gram panchayats (GPs) under the BharatNet Phase 3 programme, and has started supplying its network ...
Attempt saved. Kyle Cameron (Bromley) header from the right side of the six yard box is saved in the top right corner by Joe Murphy (Tranmere Rovers). Assisted by Lakyle Samuel with a cross. Attempt ...
The project to transform the Valley Gardens area of the city is moving into a new phase. With work almost complete on the eastern side of the Old Steine, Brighton & Hove City Council will soon be ...
ANAVEX3-71-SZ-001 achieved its primary endpoint demonstrating safety and tolerability in adults with schizophrenia Encouraging trends observed in biomarkers support continued development NEW YORK, Oct ...
- Orelabrutinib, a highly selective CNS-penetrant, oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with best-in-class potential now in Phase 3 development for progressive forms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback